J. Frederick Pritchard

953 total citations
31 papers, 755 citations indexed

About

J. Frederick Pritchard is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, J. Frederick Pritchard has authored 31 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Pharmacology and 8 papers in Molecular Biology. Recurrent topics in J. Frederick Pritchard's work include Nausea and vomiting management (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Cancer Treatment and Pharmacology (6 papers). J. Frederick Pritchard is often cited by papers focused on Nausea and vomiting management (6 papers), Pharmacogenetics and Drug Metabolism (6 papers) and Cancer Treatment and Pharmacology (6 papers). J. Frederick Pritchard collaborates with scholars based in United States, United Kingdom and Netherlands. J. Frederick Pritchard's co-authors include Dennis W. Schneck, A. Hayes, Alan Bye, Poe‐Hirr Hsyu, L.F. Lacey, Oliver N. Keene, Arthur H. Hayes, Liang‐Shang Gan, Dhiren R. Thakker and Judy C. Bryson and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

J. Frederick Pritchard

31 papers receiving 705 citations

Peers

Countries citing papers authored by J. Frederick Pritchard

Since Specialization

Citations

This map shows the geographic impact of J. Frederick Pritchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Frederick Pritchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Frederick Pritchard more than expected).

Fields of papers citing papers by J. Frederick Pritchard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Frederick Pritchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Frederick Pritchard. The network helps show where J. Frederick Pritchard may publish in the future.

Co-authorship network of co-authors of J. Frederick Pritchard

This figure shows the co-authorship network connecting the top 25 collaborators of J. Frederick Pritchard. A scholar is included among the top collaborators of J. Frederick Pritchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Frederick Pritchard. J. Frederick Pritchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Bilateral ovarian involvement at presentation in metastatic (stage 4) neuroblastoma	Pediatric Radiology	Kieran McHugh, J. Frederick Pritchard et al.	3
2	Common noncompartmental pharmacokinetic variables: are they normally or log-normally distributed?	Journal of Biopharmaceutical Statistics	L.F. Lacey, Oliver N. Keene et al.	104
3	Effects of Hemodialysis on Plasma Protein Binding of Bepridil	The Journal of Clinical Pharmacology	J. Frederick Pritchard, Gary R. Matzke et al.	3
4	Ondansetron Absorption in Adults: Effect of Dosage Form, Food, and Antacids	Journal of Pharmaceutical Sciences	Haig Bozigian, J. Frederick Pritchard et al.	25
5	Validation of a liquid chromatography post-column derivatization assay for the determination of cisplatin in plasma	Journal of Pharmaceutical and Biomedical Analysis	P. Hsyu, J. Frederick Pritchard et al.	19
6	Comparison of the Pharmacokinetics of an Ondansetron Solution (8 mg) When Administered Intravenously, Orally, to the Colon, and to the Rectum	Pharmaceutical Research	Poe‐Hirr Hsyu, J. Frederick Pritchard et al.	29
7	Mechanism of Intestinal Absorption of Ranitidine and Ondansetron: Transport Across Caco-2 Cell Monolayers	Pharmaceutical Research	Liang‐Shang Gan, Poe‐Hirr Hsyu et al.	83
8	Disposition of bepridil in laboratory animals and man	Xenobiotica	W. N. Wu, J. Frederick Pritchard et al.	11
9	Age and gender effects on ondansetron pharmacokinetics: Evaluation of healthy aged volunteers	Clinical Pharmacology & Therapeutics	J. Frederick Pritchard, Judy C. Bryson et al.	71
10	Metastatic neuroblastoma: new abnormalities on bone scintigraphy may not indicate tumour recurrence	Skeletal Radiology	Margaret Hall‐Craggs, D. Shaw et al.	3
11	Antiemetic Efficacy and pharmacokientic Analysis of the Serotonin Antagonist Ondansetron (GR 38032F) During Multiple-Day Chemotherphy With Cisplatin Prior to Autologous Bone Marrow Transplantation	JNCI Journal of the National Cancer Institute	Hillard M. Lazarus, Judy C. Bryson et al.	24
12	Suppression of rat mammary cancer development by N-(4-hydroxy-phenyDretinamide (4-HPR) following surgical removal of first palpable tumor	Carcinogenesis	Richard C. Moon, J. Frederick Pritchard et al.	43
13	Effect of tolmetin glycine amide (McN-4366), a prodrug of tolmetin sodium, on adjuvant arthritis in the rat.	Journal of Pharmacology and Experimental Therapeutics	J. Frederick Pritchard, Siu‐Fun Wong et al.	13
14	Plasma Protein Binding of Bepridil	The Journal of Clinical Pharmacology	J. Frederick Pritchard, L. A. McKown et al.	15
15	Zomepirac‐Aspirin Interactions in Man	The Journal of Clinical Pharmacology	R. K. Nayak, J. Frederick Pritchard et al.	4
16	Influence of uremia, hemodialysis, and nonesterified fatty acids on zomepirac plasma protein binding	Clinical Pharmacology & Therapeutics	J. Frederick Pritchard, Patrick J. O’Neill et al.	7
17	The inhibitory effect of propranolol pretreatment on its own metabolism in the rat.	Journal of Pharmacology and Experimental Therapeutics	Dennis W. Schneck, J. Frederick Pritchard	40
18	Effect of dose and uremia on plasma and urine profiles of propranolol metabolites	Clinical Pharmacology & Therapeutics	Dennis W. Schneck, J. Frederick Pritchard et al.	15
19	Determination of propranolol and six metabolites in human urine by high-pressure liquid chromatography	Journal of Chromatography B Biomedical Sciences and Applications	J. Frederick Pritchard, Dennis W. Schneck et al.	50
20	The contribution of propranolol metabolites to the fluorometric assay of propranolol in human plasma	Clinical Biochemistry	J. Frederick Pritchard, Dennis W. Schneck et al.	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact